Plasma atrial natriuretic factor concentrations were measured in 44 patients with mild untreated essential hypertension and 48 normotensive controls. Mean venous plasma atrial natriuretic factor concentrations were 13-2 (SEM 1.5) and 13.0 (1-3) ng/l in the hypertensive patients and controls, respectively. Plasma atrial natriuretic factor concentrations were significantly correlated with age in both groups.
Introduction
Atrial natriuretic factor is a peptide hormone with potent diuretic, natriuretic, and vasoactive properties.'2 Atrial natriuretic factor may be measured in plasma by radioimmunoassay, either directly or after extraction,3-5 and concentrations may be influenced by salt intake,67 as well as by heart failure,48 cirrhosis,6 renal failure,9 atrial tachycardia,'°and pregnancy." Because atrial natriuretic factor increases sodium excretion and decreases blood pressure, certainly after exogenous administration,'2"'4 it may be postulated that atrial natriuretic factor plays a part in essential hypertension. Arendt et al,'5 Sugawara et al, '6 and Sagnella et all" have reported finding higher plasma atrial natriuretic factor concentrations in patients with essential hypertension than in normotensive subjects.
The aims of this study were to see whether plasma atrial natriuretic factor concentrations were increased in patients with essential and renovascular hypertension and also to examine the possible relations between atrial natriuretic factor and blood pressure, heart rate, and the renin-aldosterone state of the patient.
Subjects and methods
Ambulatory patients with essential hypertension were recruited between 1 November 1985 and 28 February 1986 provided that on more than two occasions their systolic blood pressure had been higher than 150 mm Hg or their diastolic blood pressure higher than 90 mm Hg. All patients were evaluated and followed up at the hypertension clinic of the Montreal Clinical Research Institute. The diagnosis of essential hypertension had to be established before the study based on the absence of any clinical evidence of secondary hypertension; normal laboratory findings including results of a complete blood count, estimations of serum glucose, urea nitrogen, creatinine, and sodium and potassium concentrations, and urine analysis; and a hypertensive intravenous pyelogram. When clinically indicated (15 cases) a renogram and renal arteriogram were obtained. Blood pressure (standard mercury sphygmomanometer) and heart rate were measured after 10 minutes in the supine position, diastolic pressure being read at phase V of Korotkoff sounds. Blood was then drawn for the determination of plasma atrial natriuretic factor concentration, peripheral renin activity, and aldosterone value. Height (without shoes) and weight (light clothes) were measured. Patients with essential hypertension were included ifthey had not been treated with antihypertensive agents or if such treatment had been discontinued at least three weeks before the study. Patients were excluded if they had evidence of target organ damage such as ventricular hypertrophy, proteinuria ofgreater than 200 mg a day, or a serum creatinine concentration greater than 150 mmol/l.
Eight other patients were found to have renovascular hypertension in the course of their investigation. The diagnosis was established (a) by finding stenosis of a renal artery (80%); (b) by a decreased renal blood flow on the side of the stenosis, as seen in the renogram; and (c) by a renal vein ratio of plasma renin activity greater than 1-5 on the side of the stenosis versus the contralateral side. In these patients plasma atrial natriuretic factor concentrations were determined during renal vein catheterisation.
During the same period a group of healthy normotensive volunteers who had not taken any drugs were asked to serve as controls. Subjects were included if they had a normal physical examination and normal laboratory test results, including a complete blood count, biochemical profile (sequential multiple analysis 20) , and urine analysis. Smoking or a familial history of hypertension was not a reason for exclusion. They were excluded, however, if their systolic blood pressure was greater than 145 mm Hg or if their diastolic blood pressure was equal to or greater than 90 mm Hg. Controls followed the same protocol as the patients with essential hypertension with regard to blood pressure and heart rate measurements as well as to the determination of plasma atrial natriuretic factor concentrations, plasma renin activity, and aldosterone concentrations.
Analytical methods-Plasma atrial natriuretic factor concentrations were determined by radioimmunoassay according to the method of Gutkowska et al after extraction of plasma.3 Plasma renin activity' and plasma aldosterone concentrations' were determined by radioimmunoassay.
Statistical analysis-Results are expressed as means and the range, standard error ofthe mean (SEM), or 95% confidence interval. To determine the significance of differences between means analysis of covariance was used in order to account for age. The significance of a relation between two variables was assessed by Pearson's coefficient of correlation and by partial correlations in order to account for possible confounding factors. Statistical analyses were done using the statistical package for the social sciences. In the analysis of covariance hypertensive patients were compared with controls and women compared with men. x2 Analysis was used to test the difference in male to female ratio between controls and patients. The p value for significance was set at 0 05. 
Results

STUDY GROUPS
The study groups comprised 44 patients with essential hypertension and 48 normotensive controls. Table I gives their clinical and laboratory details. Though there were proportionally more men in the hypertensive group, there was no significant interaction between the study group and sex for any variable listed. Mean age and height were similar in the two groups, whereas patients tended to be heavier. On the other hand, patients with essential hypertension had similar plasma renin activities and aldosterone concentrations to the normotensive controls. These results take into account possible differences in age; height and plasma renin activity decreased with age, whereas systolic and diastolic blood pressures increased. Finally, nine patients had received antihypertensive agents in the past (diuretics, three patients; fB blockers, three; others, three). Figure 1 shows the individual and mean plasma atrial natriuretic factor concentrations in the normotensive and hypertensive subjects. Mean plasma atrial natriuretic factor concentrations were 13-2 (SEM 1 5) ng/l in the hypertensive patients and 13-0 (1 3) ng/l in the normotensive controls. This small difference was not significant (95% confidence interval -1-9 to 1-8 ng/l). Plasma atrial natriuretic factor concentrations tended to be higher in women controls (mean (1-9) ng/l) than in normotensive men (9-1 (1-3) ng/1).
Plasma atrial natriuretic factor concentrations were significantly correlated with age both in the hypertensive patients (r=0-52; p<0-001) and in the normotensive controls (r=0-35; p<002). The regression coefficients for this correlation were 0-38 in the hypertensive patients and 0-14 in the controls. These values were not significantly different and remained similar when allowing for sex. In the patients plasma atrial natriuretic factor concentration was not significantly correlated with systolic or diastolic blood pressure, nor with heart rate or plasma aldosterone concentration; plasma atrial natriuretic factor concentration, however, was negatively correlated with plasma renin activity (r=-0-50; p<005), though this correlation disappeared after correction for age. In the normotensive controls plasma atrial natriuretic factor values were significantly correlated with systolic blood pressure (r=0-35; p<0 02) and negatively with both height (r= -0-53; p<0 001) and weight (r=-0-35; p<0 02); these correlations were not improved by correction for age. Figure 2 shows the changes in plasma atrial natriuretic factor concentrations with age in the two groups.
PLASMA ATRIAL NATRIURETIC FACTOR CONCENTRATIONS AND RENOVASCULAR HYPERTENSION
Plasma atrial natriuretic factor concentrations were determined in the eight patients found to have renovascular hypertension (table II) . In each case blood was obtained from the renal vein on both sides, from the inferior vena cava at infrarenal level, and from the aorta. Plasma atrial natriuretic factor concentrations in the inferior vena cava and aorta were significantly higher in these patients than in the seven subjects with essential hypertension who were submitted to the same investigation. Plasma atrial natriuretic factor concentrations in the renal veins also tended to be higher but not significantly so. 
Discussion
Atrial natriuretic factor has potent diuretic, natriuretic, and vasodilatory activities when injected or infused into animals and man.6 12 13223 There is growing evidence that atrial natriuretic factor may have a role in volume homoeostasis through actions on receptors in the kidneys,23 adrenals, or vessel walls.2s26 There is, however, no published evidence that small changes in atrial natriuretic factor concentration, as reported after alteration of sodium intake or position, influence volume homoeostasis or blood pressure control.
Sagnella et al reported an increase in the plasma concentration of atrial natriuretic factor in a group of 28 patients with essential hypertension (mean blood pressure 164 (3)/103 (2) mm Hg).'7 We did not find such an increase in our series of 44 patients with essential hypertension, though their blood pressure was signifi- cantly higher than that in the control group of 48 normotensive volunteers. The difference between the two results is difficult to explain: our study was larger, in both numbers of controls and numbers of hypertensive patients, but the patients reported on by Sagnella et al had higher blood pressures; both studies excluded patients with end organ damage. Though the studies differed in the posture of the subjects at sampling,'7 this should not affect the comparison between hypertensive patients and normotensive controls. The duration of the hypertension was not known in either study and may have been a factor. Most patients in both studies had never been given antihypertensive drugs. Diet may also have been a factor if our patients with essential hypertension were adhering strictly to a low sodium diet. Urinary collections were not obtained; nevertheless, plasma renin activity and aldosterone values were identical in both groups. In our study plasma atrial natriuretic factor concentrations in hypertensive patients correlated significantly with age and negatively with plasma renin activity; this second -correlation, however, may have been accounted for by age. Whether the increase in atrial natriuretic factor concentration with aging contributes to the gradual decline ofplasma renin activity with aging needs further investigation, as the cause of this reduction has not been clarified. 28 Atrial natriuretic factor has been shown experimentally to be an inhibitor of renin secretion.-9 In our patients with renovascular hypertension, however, plasma atrial natriuretic factor concentrations were comparatively high despite raised plasma renin activity.
Factors such as blood volume,"S dietary sodium,3' posture,' and exercise32 are known to be implicated in the release of atrial natriuretic factor. The gradual increase of the plasma concentration ofatrial natriuretic factor with age in normal volunteers and patients with essential hypertension may be explained by a combination of many factors but, more specifically, by a reduced metabolic clearance, an increased systolic pressure, and a reduction in the ventricular ejection fraction. 33 The level of systolic pressure by itself is probably not an independent factor in most cases unless the pressure has been raised for very long periods, causing an increased pressure in both atria or left ventricular hypertrophy. After correction for age we could not show a correlation between systolic pressure and atrial natriuretic factor values. The combination of increasing age, systolic pressure with changes in pressure-volume relation may be determinant factors in the release of atrial natriuretic factor in a subject who otherwise has no evidence of cardiac or renal failure.
The increased plasma concentrations ofatrial natriuretic factor in the patients with renovascular hypertension may also have been the result of a combination of factors such as raised blood pressure and age, but probably were mainly due to secondary hyperaldosteronism associated with the renal artery stenosis. This hyperaldosteronism would cause sodium retention and then increase plasma volume enough to raise the plasma atrial natriuretic factor concentration in the presence of hypertension. The blood pressure by itself may not be the main factor, as the patients with essential hypertension at a similar age and blood pressure had plasma concentrations of atrial natriuretic factor which were 50% lower.
The relation between the plasma concentration of atrial natriuretic factor and the blood pressure is not clear. It has been reported that patients with essential hypertension have an increased central venous pressure3m as well as raised pulmonary systolic and diastolic pressures.35 Hence our results are compatible with the possibility of a reduced responsiveness in the release of atrial natriuretic factor in patients with essential hypertension, as they have normal plasma concentrations of atrial natriuretic factor despite increased blood pressure.
Introduction
The glycaemic response to standard test meals of various foods varies considerably in both normal volunteers and diabetics.'2 Thorburn et al recently reported that adding salt to two common starchy foods resulted in an increase of the postprandial plasma glucose and insulin responses. association between plasma insulin concentrations and blood pressure. Both Berglund et al and Lucas et al found higher insulin concentrations in obese hypertensive patients than in normotensive subjects with the same body mass index.45 Also in non-diabetic normotensive subjects significant associations of systolic and diastolic blood pressure with insulin concentrations have been observed even after allowing for adiposity. 6 The possible influence of salt on glucose and insulin responses might therefore be implicated in the effect of dietary salt restriction on blood pressure in essential hypertension.
We have studied the plasma glucose response to a moderate amount of salt added to two foods containing 50 g carbohydratenamely, a readily absorbed glucose solution and boiled macaroni.
Subjects and methods
Eight healthy normotensive volunteers with a normal body mass index took a test meal on four consecutive mornings after an overnight fast. Meals were allocated at random according to a Latin square model and comprised 50 g carbohydrate as either 71 g macaroni boiled for 10 minutes (intrinsic salt content 3-6 mg) or 250 ml 20% glucose with and without the addition of 6 g sodium chloride. The salt supplement was the only additive allowed. Zero time was taken as the time that eating started, and the meal had to be finished in 10 minutes.
Blood samples were drawn from an indwelling antecubital venous cannula for measurement of glucose concentration in the fasting state and every 15 minutes thereafter until 180 minutes after eating was begun. Plasma glucose concentrations were measured by a glucose oxidase method (Yellow Springs glucose analyser, Ohio, USA).
Results are expressed as medians and ranges. Incremental areas under the three hour glucose curves above fasting values were calculated. The Wilcoxon test for paired observations was used for assessing differences between salted and unsalted meals. The 95% confidence intervals for the
